Sign in
4

Changes in Ownership

Milestone Pharmaceuticals Inc. Filed Acc 0001209191-23-010703

Options or other derivatives

  • CFO & EVP of Corp. Development acquired 130,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Hasija Amit CFO & EVP of Corp. Development 2023-02-16 Grant or award · Employee Stock Option (right to buy) +130,000 130,000 D
Loading xslF345X03/doc4.xml…